NCT03836248

Brief Summary

The management of chronic low back pain is now part of a multi-disciplinary set of proposals with the aim of adapting for each patient orientations of both medicated and non-medicated care. Very classically, analgesic treatment of stage I or II is of use, reinforced by the occasional use of NSAIDs in the absence of contraindication. In this medical attempt of the control of the pain associates a physical care (supervised exercises, physiotherapy care), cognitive and behavioral therapy, multidisciplinary care. Osteopathic treatment is a specific manual diagnostic and therapeutic procedure. This study aims to evaluate the relevance of providing osteopathic treatment in combination with classical medical treatment in the management of patients with chronic non-specific low back pain.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
199

participants targeted

Target at P75+ for not_applicable

Timeline
29mo left

Started Oct 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Oct 2019Sep 2028

First Submitted

Initial submission to the registry

February 7, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 11, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

October 2, 2019

Completed
8.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

March 6, 2026

Status Verified

March 1, 2026

Enrollment Period

8.7 years

First QC Date

February 7, 2019

Last Update Submit

March 5, 2026

Conditions

Keywords

Osteopathic treatmentSham osteopathic treatmentLow back pain

Outcome Measures

Primary Outcomes (1)

  • Pain VAS Visual Analog Scale

    The primary outcome is the change in the VAS score on a 0-100 mm scale between Day 0 (before the placement of any osteopathic manipulations for Arm 3 ( or sham osteopathic treatment for Arm 2) and J90 ( after the last osteopathic treatment session for Arm 3 (sham osteopathic treatment for Arm 2)).

    Change from baseline to 3 months

Secondary Outcomes (7)

  • Pain VAS , level improvement

    Baseline, Day 15, Month 1, Month 2, Month 3, Month 6

  • Relief Numerical scale

    Day 15, Month 1, Month 2, Month 3, Month 6

  • Drug consumption

    Baseline, Day 15, Month 1, Month 2, Month 3, Month 6

  • Hand-Ground Distance and Schöber test

    Baseline, Day 15, Month 1, Month 2, Month 3, Month 6

  • Oswestry score

    Baseline, Day 15, Month 1, Month 2, Month 3, Month 6

  • +2 more secondary outcomes

Study Arms (3)

1-Current practice Medication treatment

OTHER

Medication treatment according to current practice.

Other: Current practice Medication treatment

2- Sham osteopathic treatment

SHAM COMPARATOR

Medication treatment according to current practice + sham osteopathic treatment.

Other: Sham osteopathic treatmentOther: Current practice Medication treatment

3- Osteopathic treatment

EXPERIMENTAL

Medication treatment according to current practice + osteopathic treatment.

Other: Osteopathic treatmentOther: Current practice Medication treatment

Interventions

5 osteopathic treatment sessions lasting 20 to 40 minutes. Each session include diagnosis according to the specific methodology "geometric model of osteopathy" and treatment of necessary elements and a control of osteopathic treatment at the end of the session.

3- Osteopathic treatment

5 sham osteopathic treatment sessions lasting 20 to 40 minutes. Each session include diagnosis according to the specific methodology "geometric model of osteopathy" and only contacts for no intent to treat. At the end of the session a control of the sham osteopathic treatment is performed.

2- Sham osteopathic treatment

Analgesic medication of level 1 or a combination of level 1 and 2. Acetaminophen 1 g x 3 / day Ibuprofen 400mg x 3 / day

1-Current practice Medication treatment2- Sham osteopathic treatment3- Osteopathic treatment

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patient with chronic non-specific low back pain: degenerative lumbalgia and low back pain unrelated to anatomical lesions that have been evolving for more than 3 months.
  • Patient affiliated with a social security scheme or equivalent
  • Patient having signed the study informed consent form.

You may not qualify if:

  • Patient with specific low back pain: patient with one of the following pathologies: degenerative neurological pathology; infectious pathology; fracture vertebral lesion less than 1 year; vertebral osteosynthesis material or canal narrowing.
  • Patient following a treatment of the Morphinic or Neuroleptic type.
  • Pregnant, breastfeeding or parturient woman
  • Patient participating in another clinical study
  • Protected patient: Major under some form of guardianship ; Hospitalized without consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique Pasteur

Toulouse, 31076, France

RECRUITING

MeSH Terms

Conditions

Low Back Pain

Interventions

Manipulation, Osteopathic

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Barthélémy De Truchis de Varennes, MD

    Clinique Pasteur

    PRINCIPAL INVESTIGATOR
  • François Djabaku, DO

    STUDY CHAIR
  • Barthélémy De Truchis de Varennes, MD

    Clinique Pasteur

    STUDY CHAIR

Central Study Contacts

Barthélémy De Truchis de Varennes, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective monocentric study randomized into three parallel arms.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2019

First Posted

February 11, 2019

Study Start

October 2, 2019

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

September 1, 2028

Last Updated

March 6, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations